Form 4: BioAffinity Technologies CEO Maria Zannes Acquires Restricted Stock
SEC Form 4 Filing
Maria Zannes, CEO of bioAffinity Technologies, acquired 33,784 shares of restricted common stock on July 1, 2024, as part of a grant that vests monthly over 12 months.
Summary
- On July 1, 2024, Maria Zannes, the President and CEO of bioAffinity Technologies, acquired 33,784 shares of common stock.
- These shares were granted as restricted stock.
- The restricted shares will vest pro rata on a monthly basis over a 12-month period, starting August 1, 2024.
- Following this transaction, Ms. Zannes beneficially owns 243,322 shares of bioAffinity Technologies.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The grant of restricted stock to the CEO is a common practice that aligns management's interests with shareholders. It indicates confidence in the company's future, but it's not a major event.
Positives
- The acquisition of restricted stock by the CEO aligns her interests with those of the shareholders, as the vesting schedule incentivizes her to remain with the company and improve its performance.
Future Outlook
The vesting schedule of the restricted stock suggests a commitment from the CEO to remain with the company for at least the next 12 months.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This particular filing reflects a grant of restricted stock, a common practice to incentivize and retain key executives.
Stakeholder Impact
- Shareholders may view the grant of restricted stock positively, as it aligns the CEO's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Date of transaction: Maria Zannes acquired 33,784 shares of restricted common stock. |
| 08/01/2024 | Vesting start date: Restricted shares vest pro rata on a monthly basis for 12 months commencing on this date. |
| 07/02/2024 | Date of Form 4 filing. |
Keywords
Form 4, bioAffinity Technologies, Maria Zannes, restricted stock, beneficial ownership, BIAF, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.